Skip to content
Home›Awards›Novartis Pharmaceuticals Corporation
$

Federal Contract Award

Novartis Pharmaceuticals Corporation

Department of Veterans Affairs · October 29, 2026 · FY2027

36C26226N0112Set-aside not reportedNAICS 325412

Obligated

$4,299,447

Contract details

Award ID
CONT_AWD_36C26226N0112_3600_36F79720D0180_3600
PIID
36C26226N0112
Period of performance
November 1, 2025 → October 31, 2026
Place of performance
EAST HANOVER, NJ, USA
Set-aside
Not reported
Pricing type
FIRM FIXED PRICE
PSC
6505 — DRUGS AND BIOLOGICALS
NAICS
325412 — PHARMACEUTICAL PREPARATION MANUFACTURING

Scope

PLUVICTO AND LUTATHERA

Parent vehicle (IDV)

Novartis Sanierungsstiftung

UEI YE3YG1FDWMC5

This award was placed as a task/delivery order under a larger contract vehicle.

Recipient

Novartis Pharmaceuticals Corporation →
UEI
NG61ZA8TADW3
CAGE
04520
Parent
Novartis Sanierungsstiftung
Address
EAST HANOVER, NJ

Awarding agency

Department of Veterans Affairs →
Sub-agency
Department of Veterans Affairs
Office
262-NETWORK CONTRACT OFFICE 22 (36C262)
Funding agency
Department of Veterans Affairs
Funding office
691-VA GREATER LA HLTHCR SYS(00691)

See every contract Novartis Pharmaceuticals Corporation has won

Full contracting history, year-over-year trends, subaward graph, and recompete alerts.

View Novartis Pharmaceuticals Corporation profile →